feed,title,long_url,short_url
Benzinga,Forma Therapeutics High-Dose Of FT-4202 Numerically Inferior To Low Dose In Sickle Cell Disease Study,https://benzinga.com/general/biotech/21/03/20404096/forma-therapeutics-high-dose-of-ft-4202-numerically-inferior-to-low-dose-in-sickle-cell-disease-s,https://j.mp/2PEryhW
